Hormone suppression therapy may harm survival for African-American prostate cancer patients Androgen-deprivation therapy may shorten survival in African-American men with favourable-risk prostate cancer, researchers say.…
Personalised dosing technology shows promise for transplant patients A medicine platform that calculates a patient’s ideal dose is effective and has the potential to be used in other therapeutic areas, research shows.…
Third of men with advanced prostate cancer could benefit from olaparib A third of men with advanced prostate cancer could benefit from a drug currently licensed for women with ovarian cancer, according to the “remarkable” results of a study.…
Stratified medicine is changing our concept of disease Understanding the different molecular pathways behind a disease will help doctors to manage it.…
Not all NHS waste is wasteful Amidst the drive for efficiency in the NHS, medicines waste must not be oversimplified.…
Genes influence response to statins, research finds Four genes are responsible for about 5% of the variation in an individual’s response to statin treatment, research suggests.…
